
    
      Patients were enrolled in two groups. Group 1 enrolled patients who are not candidates for
      surgery. Group 2 was planned to enroll patients who are surgical candidates. Patients from
      both groups were evaluated for tumor response and progression by MRI every 8 weeks until
      disease progression or discontinuation from study using RANO criteria.
    
  